Overview
Microalbumin refers to small amounts of albumin excreted in urine that are above normal but below the detection limit of routine dipstick tests. Microalbuminuria represents an early and sensitive marker of kidney damage, particularly involving the glomerular filtration barrier. It is defined by a urinary albumin excretion of 30 to 300 mg per day and commonly reflects early renal involvement in conditions such as diabetes mellitus and hypertension. Microalbuminuria is often the first clinical indication of diabetic nephropathy and is strongly associated with increased renal and cardiovascular risk, even before overt symptoms or changes in serum creatinine become evident.
Symptoms
Microalbuminuria itself does not usually cause noticeable symptoms and is often detected only through laboratory testing. Patients are typically asymptomatic in the early stages of kidney damage. As the condition progresses and albumin excretion increases, it may indicate advancing renal dysfunction, which can later be associated with symptoms related to chronic kidney disease. Because symptoms appear late, routine screening in high-risk individuals is essential for early detection and intervention.
Causes
Microalbuminuria occurs due to structural and functional changes in the glomerular basement membrane that allow increased passage of albumin into the urine. These changes include increased glomerular permeability, thickening of the basement membrane, mesangial expansion, and podocyte injury. Inadequate tubular reabsorption may also contribute. Common causes include diabetes mellitus type 1 and type 2, persistent hypertension, glomerulonephritis, and metabolic syndrome. Endothelial dysfunction plays a central role, leading to vascular damage, inflammation, lipid accumulation, and progression toward atherosclerosis and permanent kidney injury.
Risk Factors
Individuals at increased risk of microalbuminuria include patients with diabetes, high blood pressure, insulin resistance, obesity, and metabolic syndrome. Additional risk factors include a family history of kidney disease, cardiovascular disease, and prolonged poor glycemic or blood pressure control. Transient elevations may occur with strenuous exercise, infection, dehydration, fever, or acute illness, which must be considered during interpretation. Because microalbuminuria also reflects generalized endothelial dysfunction, its presence indicates an increased risk of cardiovascular events such as heart attack and stroke.
Prevention
Prevention focuses on early screening, especially in high-risk populations, and timely management of underlying conditions. Regular monitoring of urinary albumin, preferably using the albumin creatinine ratio in a spot urine sample, allows early detection of renal damage. Optimal control of blood glucose and blood pressure, along with lifestyle modifications, helps reduce progression to overt nephropathy and chronic kidney disease. Proper sample collection, correct use of preservatives for 24-hour urine samples, and avoidance of interfering factors ensure reliable results. Early identification and monitoring of microalbuminuria support preventive strategies that reduce the risk of end-stage renal disease and associated cardiovascular complications.
